NeuMoDx gets emergency use authorization for SARS-CoV2 test

Create PDF

The NeuMoDx 288 and 96 molecular systems can provide the first test results in about 80 minutes from primary collection or daughter tubes. The NeuMoDx systems allow laboratories to validate their own SARS-Cov-2 laboratory-developed tests, including those provided by the World Health Organization and Centers for Disease Control and Prevention.